Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer

ClinicalTrials.gov ID: NCT00709826

Public ClinicalTrials.gov record NCT00709826. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 12:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

APRiCOT-P (Apricoxib in Combination Oncology Treatment - Pancreas): Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Gemcitabine and Erlotinib in the Treatment of Patients With Advanced Pancreatic Cancer

Study identification

NCT ID
NCT00709826
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Tragara Pharmaceuticals, Inc.
Industry
Enrollment
109 participants

Conditions and interventions

Interventions

  • Erlotinib Drug
  • apricoxib Drug
  • gemcitabine Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2008
Primary completion
May 31, 2010
Completion
Apr 30, 2011
Last update posted
Nov 6, 2012

2008 – 2011

United States locations

U.S. sites
39
U.S. states
25
U.S. cities
39
Facility City State ZIP Site status
Arizona Clinical Research Center Tucson Arizona 85715
Comprehensive Blood and Cancer Center Bakersfield California 93309
Southbay Oncology Hematology Partners Campbell California 95008
Bay Area Cancer Research Group, LLC Concord California 94523
Bay Area Cancer Research Group, LLC Pleasant Hill California 94523
North America Research Institute San Dimas California 91773
Front Range Cancer Specialists Fort Collins Colorado 80528
Oncology Associates of Bridgeport Trumball Connecticut 06611
Hematology Oncology Associates Lake Worth Florida 33461
Hematology Oncology Associates of Treasure Coast Port Saint Lucie Florida 34952
The Queen's Medical Center Cancer Center Honolulu Hawaii 96813
Rush-Copley Medical Center Aurora Illinois 60504
Alexian Brothers Medical Hospital Network Elk Grove Village Illinois 60007
Investigative Clinical Research of Indiana, LLC Indianapolis Indiana 46260
Medical Consultants, PC Muncie Indiana 47303
University of Iowa Hospitals Iowa City Iowa 52242
Owsley Brown Frazier Cancer Center Louisville Kentucky 40245
Jayne Gurtler, MD Metairie Louisiana 70006
Franklin Square Hospital Center/Harry and Jeanette Weinberg Cancer Institute at Franklin Square Baltimore Maryland 21237
SJMH Cancer Center Ann Arbor Michigan 48106
Nebraska Methodist Hospital Omaha Nebraska 68114
Warren Hospital Phillipsburg New Jersey 08865
San Juan Oncology Associates Farmington New Mexico 87401
Bronx River Medical Associates, P.C. The Bronx New York 10467
Cancer Care of WNC, PA Asheville North Carolina 28801
Southeastern Medical Oncology Center Goldsboro North Carolina 27534
Southeastern Medical Oncology Center Wilson North Carolina 27893
Samaritan Hematology * Oncology Corvallis Oregon 97330
Eastern Regional Medical Center Philadelphia Pennsylvania 19124
Associates in Hematology-Oncology PC Upland Pennsylvania 19013
Berks Hematology-Oncology Associates, Ltd West Reading Pennsylvania 19612
Charleston Hematology Oncology Associates Charleston South Carolina 29414
JTV Cancer Care Institute Rapid City South Dakota 57701
The Jones Clinic Germantown Tennessee 38138
Tennessee Cancer Specialists Knoxville Tennessee 37920
Coastal Bend Cancer Center Corpus Christi Texas 78463
The Center for Cancer and Blood Disorders Fort Worth Texas 76104
The Methodist Hospital Houston Texas 77030
Cascade Cancer Center Kirkland Washington 98304

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00709826, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 6, 2012 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00709826 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →